Cipla to buy Meditab for $28m
Indian pharmaceutical firm Cipla is to buy Meditab Specialties to boost active pharmaceutical ingredient (API) and intermediate production capacity.
Archives for August 24, 2010
Paediatric trial globalisation raises scientific, ethical issues
Questions about the ethics and scientific validity of trials conducted under the Pediatric Exclusivity Provision have been raised after researchers found many studies used sites outside the US.
India ponders compulsory licensing revisions to cut prices
India is considering strengthening compulsory licensing provisions, which allow third parties to produce patented products, in response to concerns about overseas takeovers and drug prices.
Aileron protein delivery tech lands potential $1bn Roche deal
Cell penetration and pharmacodynamics boosting “stapled peptide” tech wins Aileron Therapeutics potential billion dollar protein drug development deal with Roche.
Stirling Pharma’s Canadian production plant to open by late September
Stirling Pharma’s state-of-the-art Canadian plant will open its doors in late September, and first to come off the production line will be the drug, acetaminophen.
Pandemic vaccine production time could be halved in 3 years
A review of US capabilities has concluded that the time to produce a pandemic vaccine could be halved through adoption of short-term policies.
Asia Pacific trial sector poised for continued growth, says Novotech
The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients, cut costs and improve data quality according to Novotech CEO Alek Safarian.